APPLICATION
ANDA088365
TYPE
ANDA
ORIGINAL APPROVAL
1983-12-22
LATEST ACTION
1991-05-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CHLOROTHIAZIDE AND RESERPINEDiscontinued
CHLOROTHIAZIDE 500MG, RESERPINE 0.125MG · TABLET · ORAL
Approval history
1991-05-14Manufacturing (CMC) · Supplement 10AP
1983-12-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.